In vivo suppression of NK cell cytotoxicity by stress and surgery: Glucocorticoids have a minor role compared to catecholamines and prostaglandins

Brain, Behavior, and Immunity

Volumn 37, Issue , 2014, Pages 207-219

  Rosenne, Ella ^a   Sorski, Liat ^a   Shaashua, Lee ^a   Neeman, Elad ^a   Matzner, Pini ^a   Levi, Ben ^a   Ben Eliyahu, Shamgar ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Catecholamines; Glucocorticoids; In vivo; NK cell cytotoxicity; Prostaglandins

Indexed keywords

ADRENALIN; CATECHOLAMINE; CORTICOSTERONE; GLUCOCORTICOID; PROSTAGLANDIN;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIORAL STRESS; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; CORTICOSTERONE RELEASE; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; EX VIVO STUDY; FEMALE; FISCHER 344 RAT; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG CLEARANCE; LUNG METASTASIS; MALE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SEX DIFFERENCE; STRESS; T CELL DEPLETION;

CATECHOLAMINES; GLUCOCORTICOIDS; IN VIVO; NK CELL CYTOTOXICITY; PROSTAGLANDINS;

ADRENALECTOMY; ANIMALS; CATECHOLAMINES; CELL LINE, TUMOR; CORTICOSTERONE; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GLUCOCORTICOIDS; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MALE; PROSTAGLANDINS; RATS; RATS, INBRED F344; STRESS, PHYSIOLOGICAL;

EID: 84896732722     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.12.007     Document Type: Article

References (68)

1. Andersen B.L., et al. Stress and immune responses after surgical treatment for regional breast cancer. J. Natl Cancer Inst. 1998, 90(1):30-36.
2. Bankhurst A.D. The modulation of human natural killer cell activity by prostaglandins. J. Clin. Lab. Immunol. 1982, 7(2):85-91.
3. Barlozzari T., et al. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J. Immunol. 1985, 134(4):2783-2789.
4. Barlozzari T., Reynolds C.W., Herberman R.B. In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats. J. Immunol. 1983, 131(2):1024-1027.
5. Ben-Eliyahu S. Can we really know if a stressor increases or decreases natural killer cell activity?. Brain Behav. Immun. 2012, 26(8):1224-1225.
6. Ben-Eliyahu S., et al. Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis. Nat. Med. 1996, 2(4):457-460.
7. Ben-Eliyahu S., et al. Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: possible role of oestradiol and natural killer cells. Br. J. Cancer 1996, 74(12):1900-1907.
8. Ben-Eliyahu S., et al. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int. J. Cancer 1999, 80(6):880-888.
9. Ben-Eliyahu S., et al. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. NeuroImmunoModulation 2000, 8(3):154-164.
10. Ben-Eliyahu S., Page G.G. In vivo assessment of natural killer cell activity in rats. Prog. Neuroendocrineimmunol. 1992, 5:199-214.
11. Benish M., et al. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann. Surg. Oncol. 2008, 15(7):2042-2052.
12. Bodner G., Ho A., Kreek M.J. Effect of endogenous cortisol levels on natural killer cell activity in healthy humans. Brain Behav. Immun. 1998, 12(4):285-296.
13. Broug-Holub E., et al. Effects of stress on alveolar macrophages: a role for the sympathetic nervous system. Am. J. Respir. Cell Mol. Biol. 1998, 19(5):842-848.
14. Brown K.J., Grunberg N.E. Effects of housing on male and female rats: crowding stresses male but calm females. Physiol. Behav. 1995, 58(6):1085-1089.
15. Chambers W.H., et al. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J. Exp. Med. 1989, 169(4):1373-1389.
16. dim subpopulations of rat natural killer cells. J. Immunol. 1992, 148(11):3658-3665.
17. Cole S.W., Sood A.K. Molecular pathways: beta-adrenergic signaling in cancer. Clin. Cancer Res. 2012, 18(5):1201-1206.
18. Cox W.I., Holbrook N.J., Friedman H. Mechanism of glucocorticoid action on murine natural killer cell activity. J. Natl Cancer Inst. 1983, 71(5):973-981.
19. Dhabhar F.S., et al. Short-term stress enhances cellular immunity and increases early resistance to squamous cell carcinoma. Brain Behav. Immun. 2010, 24(1):127-137.
20. Glasner A., et al. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J. Immunol. 2010, 184(5):2449-2457.
21. Goldfarb Y., et al. CpG-C oligodeoxynucleotides limit the deleterious effects of beta-adrenoceptor stimulation on NK cytotoxicity and metastatic dissemination. J. Immunother. 2009, 32(3):280-291.
22. Goldfarb Y., et al. Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann. Surg. 2011, 253(4):798-810.
23. Gwosdow A.R., et al. Interleukin-1-induced corticosterone release occurs by an adrenergic mechanism from rat adrenal gland. Am. J. Physiol. 1992, 263(3 Pt 1):E461-E466.
24. Hellstrand K., Hermodsson S. An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity. Int. Arch. Allergy Appl. Immunol. 1989, 89(4):334-341.
25. Hiraki S., et al. Interleukin-18 restores immune suppression in patients with nonseptic surgery, but not with sepsis. Am. J. Surg. 2007, 193(6):676-680.
26. Holbrook N.J., Cox W.I., Horner H.C. Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon. Cancer Res. 1983, 43(9):4019-4025.
27. Inbar S., et al. Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity. PLoS ONE 2011, 6(4):e19246.
28. Irwin M., et al. Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity. J. Pharmacol. Exp. Ther. 1990, 255(1):101-107.
29. Kajantie E., Phillips D.I. The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology 2006, 31(2):151-178.
30. Koga C., et al. Anxiety and pain suppress the natural killer cell activity in oral surgery outpatients. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2001, 91(6):654-658.
31. Koren H.S., Leung K.H. Modulation of human NK cells by interferon and prostaglandin E2. Mol. Immunol. 1982, 19(10):1341-1346.
32. Landmann R. Beta-adrenergic receptors in human leukocyte subpopulations. Eur. J. Clin. Invest. 1992, 1:30-36.
33. Lee J.W., et al. Surgical stress promotes tumor growth in ovarian carcinoma. Clin. Cancer Res. 2009, 15(8):2695-2702.
34. Levi B., et al. Continuous stress disrupts immunostimulatory effects of IL-12. Brain Behav. Immun. 2011, 25(4):727-735.
35. Lewis J.G., Elder P.A. Intact or "active" corticosteroid-binding globulin (CBG) and total CBG in plasma: Determination by parallel ELISAs using monoclonal antibodies. Clin Chim Acta 2012, 90(1):30-36.
36. Melamed R., et al. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav. Immun. 2005, 19(2):114-126.
37. Melamed R., et al. The marginating-pulmonary immune compartment in rats: characteristics of continuous inflammation and activated NK cells. J. Immunother. 2010, 33(1):16-29.
38. Meron G., et al. PGE(2) suppresses NK activity in vivo directly and through adrenal hormones: Effects that cannot be reflected by ex vivo assessment of NK cytotoxicity. Brain Behav. Immun. 2012, 19(10):1341-1346.
39. Naor R., et al. Metastatic-promoting effects of LPS: sexual dimorphism and mediation by catecholamines and prostaglandins. Brain Behav. Immun. 2008, 49(2):272-280.
40. Neeman E., Ben-Eliyahu S. Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement. Brain Behav. Immun. 2013, 30(Suppl):S32-S40.
41. Neeman E., Ben-Eliyahu S. Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement. Brain Behav. Immun. 2012, 22(2):139-146.
42. Neeman E., Zmora O., Ben-Eliyahu S. A new approach to reducing postsurgical cancer recurrence: perioperative targeting of catecholamines and prostaglandins. Clin. Cancer Res. 2012, 18(18):4895-4902.
43. O'Connell N.A., et al. Interleukin-1 regulates corticosterone secretion from the rat adrenal gland through a catecholamine-dependent and prostaglandin E2-independent mechanism. Endocrinology 1994, 135(1):460-467.
44. Oosterling S.J., et al. Perioperative IFN-alpha to avoid surgically induced immune suppression in colorectal cancer patients. Histol. Histopathol. 2006, 21(7):753-760.
45. Page G.G., et al. Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain 1993, 54(1):21-28.
46. Page G.G., et al. Male-female differences in the impact of beta-adrenoceptor stimulation on resistance to experimental metastasis: exploring the effects of age and gonadal hormone involvement. J. Neuroimmunol. 2008, 193(1-2):113-119.
47. Page G., Ben-Eliyahu S., Taylor A. The development of sexual dimorphism in natural killer cell activity and resistance to tumor metastasis in the Fischer 344 rat. J. Neuroimmunol. 1995, 63(1):69-77.
48. Pruett S.B., et al. Quantitative relationships between the suppression of selected immunological parameters and the area under the corticosterone concentration vs. time curve in B6C3F1 mice subjected to exogenous corticosterone or to restraint stress. Toxicol. Sci. 1999, 49(2):272-280.
49. Reyburn H., et al. Human NK cells: their ligands, receptors and functions. Immunol. Rev. 1997, 155:119-125.
50. Rhodes M.E., Rubin R.T. Functional sex differences ('sexual diergism') of central nervous system cholinergic systems, vasopressin, and hypothalamic-pituitary-adrenal axis activity in mammals: a selective review. Brain Res. Brain Res. Rev. 1999, 30(2):135-152.
51. Seifarth J.E., McGowan C.L., Milne K.J. Sex and life expectancy. Gend. Med. 2012, 9(6):390-401.
52. Seiffert K., Granstein R.D. Neuroendocrine regulation of skin dendritic cells. Ann. NY Acad. Sci. 2006, 1088:195-206.
53. Shaashua L., et al. In vivo suppression of plasma IL-12 levels by acute and chronic stress paradigms: potential mediating mechanisms and sex differences. Brain Behav. Immun. 2012, 26(6):996-1005.
54. Shakhar G., Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J. Immunol. 1998, 160(7):3251-3258.
55. Shakhar G., Blumenfeld B. Glucocorticoid involvement in suppression of NK activity following surgery in rats. J. Neuroimmunol. 2003, 138(1-2):83-91.
56. Shakhar K., et al. Timing within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity. Br. J. Cancer 2000, 83(12):1630-1636.
57. Shakhar G., et al. Amelioration of operation-induced suppression of marginating pulmonary NK activity using poly IC: a potential approach to reduce postoperative metastasis. Ann. Surg. Oncol. 2007, 14(2):841-852.
58. Shingu K., et al. Kinetics of the early recruitment of leukocyte subsets at the sites of tumor cells in the lungs: natural killer (NK) cells rapidly attract monocytes but not lymphocytes in the surveillance of micrometastasis. Int. J. Cancer 2002, 99(1):74-81.
59. Tarr A.J., et al. Beta-adrenergic receptor mediated increases in activation and function of natural killer cells following repeated social disruption. Brain Behav. Immun. 2012, 26(8):1226-1238.
60. Tonnesen E., Tonnesen J., Christensen N.J. Augmentation of cytotoxicity by natural killer (NK) cells after adrenaline administration in man. Acta Pathologica, Microbiologica, et Immunologica Scandandinavica. Section C 1984, 92(1):81-83.
61. Torgersen K.M., et al. Selective activation of cAMP-dependent protein kinase type I inhibits rat natural killer cell cytotoxicity. J. Biol. Chem. 1997, 272(9):5495-5500.
62. Tseng R.J., et al. Stress-induced modulation of NK activity during influenza viral infection: role of glucocorticoids and opioids. Brain Behav. Immun. 2005, 19(2):153-164.
63. Vallejo R., et al. Perioperative immunosuppression in cancer patients. J. Environ. Pathol. Toxicol. Oncol. 2003, 22(2):139-146.
64. Van Ierssel A.J., et al. Suppression of intestinal mucosal natural killer cells by corticosteroids. Aliment. Pharmacol. Ther. 1997, 11(2):347-353.
65. Whalen M.M., Bankhurst A.D. Effects of beta-adrenergic receptor activation, cholera toxin and forskolin on human natural killer cell function. Biochem. J. 1990, 272(2):327-331.
66. Witek-Janusek L., et al. Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav. Immun. 2008, 22(6):969-981.
67. Yakar I., et al. Prostaglandin e(2) suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats. Ann. Surg. Oncol. 2003, 10(4):469-479.
68. Zagron G., Weinstock M. Maternal adrenal hormone secretion mediates behavioural alterations induced by prenatal stress in male and female rats. Behav. Brain Res. 2006, 175(2):323-328.